This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
While the court addressed multiple issues, I want to focus here on the damages analysis - particularly regarding comparable licenses and apportionment. The damages dispute focused primarily on how Altria's expert derived a 5.25% royalty rate from comparable license agreements, particularly a license between Fontem and Nu Mark.
It is a prescription drug for treating HIV in adults, available in tablet and injectable forms, and is used in combination with other HIV medicines, currently licensed for treatment, not prevention, due to its high prices. The looming threat is the pending patent applications by Gilead in India.
Nearly a decade after the establishment of the seventeen UN Sustainable Development Goals ( SDGs ) in Agenda 2030, this volume brings together 25 excellent contributions to reflect on the role of intellectual property in the progress of the SDGs. Ncube and Matthew Rimmer. That's not a Kat. but it does care about the environment!
IP: Tool for Promotion of Innovation The UN’s 2030 Agenda for Sustainable Development, adopted in 2015, aims to promote global sustainable development but often excludes intellectual property (IPR) due to the challenges in establishing standards and practical meaning.
1 For example, Ford and BMW announced in May 2021 that they had invested $130m in solid-state battery start-up Solid Power to deliver batteries that will be deployed in EVs by 2030. For battery-related patents, in particular, it is important to consider where and how big the present markets are for the invention.
7 And with President Joe Biden’s recent executive order setting a target for zero-emissions vehicles to account for half of all automobiles sold in the United States by 2030, solid-state battery development likely will kick into even higher gear over the course of the decade. Policy Considerations.
A compulsory license is a government-granted authorization that allows third parties to use, produce, or sell a patented product or process without the patent holders consent, aiming to benefit the public. However, they can also create barriers to access by making technologies expensive and restricting their use through licensing agreements.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content